Overview

Bevacizumab Treatment and Retinal Vessel Monitoring

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Bevacizumab might influence the dynamic vessel function after being administered intravenously.
Details
Lead Sponsor:
Technische Universität Dresden
Treatments:
Bevacizumab